HSV IgG Seroconversion Timeline
HSV IgG antibodies typically become detectable up to 12 weeks after exposure, and testing before this window frequently yields false-negative results. 1
Antibody Development Window
- Detectable IgG antibodies may not appear until 12 weeks post-exposure, making earlier testing unreliable 1
- Testing performed before 12 weeks should be deferred, with repeat testing recommended no sooner than 12 weeks after suspected exposure 1
- Research data shows that sera collected at least 21 days after onset of primary HSV-2 infection detect antibodies in 99% of cases by Western blot and 96% by glycoprotein G-specific assays 2
- In contrast, sera drawn earlier than 21 days from primary HSV-2 onset detect antibodies in only 25% by Western blot and 8% by immunodot enzyme assay 2
Clinical Algorithm for Testing Timing
- If exposure occurred within the past 12 weeks: Do not rely on serology; a negative result is unreliable and repeat testing after 12 weeks is necessary 1
- If active lesions are present: Skip serology entirely and perform direct lesion testing with NAAT/PCR, which is the preferred diagnostic approach 1
- If exposure occurred >12 weeks ago without lesions: Serology is more trustworthy, particularly for HSV-2 testing 1
Critical Caveats About Test Sensitivity
Even after the 12-week window, commercial HSV antibody assays have significant limitations:
- HSV-1 IgG assays have only ~70% sensitivity, meaning approximately 30% of truly infected individuals will test false-negative 1
- HSV-2 IgG assays are more sensitive at ~92%, but still miss about 8% of true infections 1
- Recent validation studies confirm HSV-1 IgG sensitivity remains below 85% across major automated platforms 3
Common Pitfall to Avoid
Never tell a patient that a negative HSV serology definitively proves lack of prior exposure, especially for HSV-1 where the false-negative rate approaches 30% 1. When clinical suspicion remains high despite negative serology obtained within 12 weeks, either wait and retest after 12 weeks or pursue direct lesion testing if lesions develop 1.